Erste Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Erste Asset Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-24,900	Closed	-$1.87M	–	577
2022 Q2	$1.87M	Hold	24,900	–	–	0.04%	286
2022 Q1	$671K	Buy	24,900 +6,200	+33%	+$208K	0.01%	408
2021 Q4	$876K	Hold	18,700	–	–	0.02%	373
2021 Q3	$1.27M	Hold	18,700	–	–	0.03%	317
2021 Q2	$1.42M	Hold	18,700	–	–	0.03%	322
2021 Q1	$1.67M	Hold	18,700	–	–	0.04%	294
2020 Q4	$2.25M	Sell	18,700 -4,800	-20%	-$526K	0.06%	251
2020 Q3	$2.08M	Hold	23,500	–	–	0.07%	241
2020 Q2	$1.5M	Hold	23,500	–	–	0.06%	261
2020 Q1	$1.04M	Buy	+23,500	New	+$1.25M	0.06%	251

Erste Asset Management's TPTX Position: Q3 2022 in Review

Erste Asset Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 24,900 shares — an estimated $1.87M sold.

Erste Asset Management first reported a position in TPTX in Q1 2020 and held it in 10 quarters. The position peaked at $2.25M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Erste Asset Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Erste Asset Management sold 24,900 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.87M.
Erste Asset Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2020 and held it in 10 quarters.
Erste Asset Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $2.25M in Q4 2020.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Erste Asset Management's 13F filing for Q3 2022, filed 26 Nov 2024.